ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $264,000 | +125.6% | 22,236 | 0.0% | 0.01% | +133.3% |
| Q1 2019 | $117,000 | +67.1% | 22,236 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $70,000 | -48.1% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $135,000 | +14.4% | 22,236 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $118,000 | -8.5% | 22,236 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $129,000 | +65.4% | 22,236 | 0.0% | 0.01% | +66.7% |
| Q4 2017 | $78,000 | -3.7% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $81,000 | +44.6% | 22,236 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $56,000 | -6.7% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $60,000 | -6.2% | 22,236 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $64,000 | -29.7% | 22,236 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $91,000 | +30.0% | 22,236 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $70,000 | – | 22,236 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |